CX 2015 CX Innovation Showcase 2016-10-12T13:00:59+00:00

CX Innovation Showcase

Tuesday 28 April – Pillar Hall Learning Centre

Course directors: Stephen Greenhalgh and Andrew Holden

The CX Innovation Showcase is dedicated to highlighting what it takes for a physician-inventor to succeed and for innovative ideas in the vascular and endovascular to thrive. It brings together leading industry experts, physician-inventors, engineers, medtech investors and start-up companies focused on improving vascular disease management.

jQuery UI Accordion - Default functionality
CX Innovation Showcase
Chairing: Stephen Greenhalgh, London, United Kingdom
Chairing: Andrew Holden, Auckland, New Zealand
Endovascular aortic innovation 08:30-08:35 agili-D endograft (Altura)
Albrecht Kramer, Santiago, Chile
08:35-08:40 Discussion 08:40-08:45 Horizon endograft for EVAR (Endospan)
Gioachino Coppi, Modena, Italy
08:45-08:50 Discussion 08:50-08:55 Randomised controlled trial of fascia suture vs. Prostar in patients undergoing endovascular aortic repair
Thomas Larzon, Orebro, Sweden
08:55-09:00 Discussion 09:00-09:05 In vivo antegrade fenestration of renal arteries in pararenal AAA
Bao Bui, Sherbrooke, Canada
09:05-09:10 Panel discussion Complex aortic endografting innovation 09:10-09:15 Nexus endograft with branch and fenestrations for total arch repair
Mario Lachat, Zurich, Switzerland
09:15-09:20 Discussion 09:20-09:25 Najuta endograft for total branch repair
Shin Ishimaru, Saitama, Japan
09:25-09:30 Discussion 09:30-09:35 Pararenal non-anatomical branch endograft system
Patrick W Kelly, Sioux Falls, United States
09:35-09:40 Discussion 09:40-09:45 Spiral vein reconstruction using the greater saphenous vein to reconstruct a neo-aorta in infected cases
Jan Heyligers, Tilburg, Netherlands
09:45-09:50 Discussion 09:50-10:00 Gore thoracoabdominal branch endoprosthesis: early clinical results
Pierre Galvagni Silveira, Florianopolis, Brazil
10:00-10:30 COFFEE Peripheral innovations 10:30-10:40 Shockwave technology
Todd Brinton, Stanford, United States
10:40-10:45 Discussion 10:45-10:55 Helical 3D stenting
Stephen Williams, Baltimore, United States
10:55-11:00 Discussion 11:00-11:10 Early results of paclitaxel infusion AFTER endorevascularisation
Patrick W Kelly, Sioux Falls, United States
11:10-11:15 Discussion 11:15-11:25 Regeneration medicine in peripheral arterial disease
Howard Leonhardt, Santa Monica, United States
11:25-11:30 Discussion 11:30-11:40 Biomechanical approaches to resolving lymphoedema
Jimmy Moore, London, United Kingdom
11:40-11:45 Discussion 11:45-11:55 Bioresorbable scaffolds in lower limb arteries
Andrew Holden, Auckland, New Zealand
11:55-12:00 Discussion Diagnostic innovation 12:00-12:10 Empowerment of nurses in vascular investigations
David King, London, United Kingdom
12:10-12:15 Discussion Vascular access innovation 12:15-12:25 First-in-man experience with the Cook Scoring balloon in haemodialysis fistula stenosis
Andrew Holden, Auckland, New Zealand
12:25-12:30 Discussion 12:30-13:30 LUNCH "Speed Dating" and "Dragons Den" 13:30-14:30 The “Speed Dating” session provides networking opportunities with leaders in the world of vascular innovations including physician-inventors, engineers and marketing experts. Participating in this session will give you the opportunity to soundboard your idea and receive valuable feedback from thought-leaders. 14:30-15:30 Unique in calling for innovative ideas and technologies to be submitted for participation in its “Dragons’ Den” session, the CX Innovation Showcase will be awarding a £1,000 prize to the best innovation. Dragons
Panel: Bob Mitchell, Irvine, United States
Panel: Robert Whirley, Santa Rosa, United States
Panel: Louise Verheij van Wijk, Best, Netherlands
Panel: James Reinstein, Sunnyvale, United States
Panel: Daveen Chopra, Santa Rosa, United States
Panel: Chas Taylor, Horsham, United Kingdom
Panel: Jason Field, Flagstaff, United States
15:30-16:00 TEA Town Hall Session
Chairing: Stephen Greenhalgh, London, United Kingdom
Chairing: Roger Greenhalgh, London, United Kingdom
The new CX Town Hall Session is aiming to explore the balance between Medtech advancement and regulatory procedures and will include talks and discussions about the proper relationship between vascular specialists, the endovascular device industry and regulatory bodies. 16:00-16:05 Introduction
Roger Greenhalgh, London, United Kingdom
16:05-16:10 Innovator perspective
Andrew Holden, Auckland, New Zealand
16:10-16:15 Innovator perspective
Frans Moll, Utrecht, Netherlands
16:15-16:20 Questions and Discussion 16:20-16:25 Entrepreneur perspective
Chas Taylor, Horsham, United Kingdom
16:25-16:30 Entrepreneur perspective
Alan Edwards, Ruthin, United Kingdom
16:30-16:35 Questions and Discussion 16:35-16:40 University technology licensing perspective
Andrew Tingey, London, United Kingdom
16:40-16:45 Questions and Discussion 16:45-16:50 Company perspective
Tony Semedo, Santa Rosa, United States
16:50-16:55 Company perspective
Bob Mitchell, Irvine, United States
16:55-17:00 Questions and Discussion 17:00-17:05 Regulatory perspective: FDA
Jose Pablo Morales, Silver Spring, United States
17:05-17:10 Questions and Discussions 17:10-17:15 One-to-one teaching of techniques
Ian Franklin, London, United Kingdom
17:15-17:20 One-to-one teaching of techniques
Stephen Black, London, United Kingdom
17:20-17:25 Global congresses
Frank Veith, New York, United States
17:25-17:30 Questions and Discussion 17:30-17:35 Regulatory perspective: Eucomed
Serge Bernasconi, Brussels, Belgium
17:35-17:40 Questions and Discussion 17:40-18:00 Panel discussion